Source comparison
Best NAD+ Dosage for Mitochondrial Health: Delivery Method Comparison
Sublingual NR/NMN 250–500mg 30–40% Once daily (morning) 40–90% increase in whole-blood NAD+ after 4–8 weeks Optimal balance of efficacy, convenience, and cost. Recommended for sustained mitochondrial support in research settings Oral capsules (NR/NMN) 500–1000
This comparison does not assign a generated winner or score.
- Sublingual NR/NMN
- 250–500mg
- 30–40%
- Once daily (morning)
- 40–90% increase in whole-blood NAD+ after 4–8 weeks
- Optimal balance of efficacy, convenience, and cost. Recommended for sustained mitochondrial support in research settings
- Oral capsules (NR/NMN)
- 500–1000mg
- 10–20%
- Once or twice daily
- 30–60% increase after 6–12 weeks
- Requires higher doses to compensate for degradation. Use enteric-coated formulations to improve absorption
- IV NAD+
- 250–750mg per session
- 95–100%
- Weekly to biweekly
- Immediate but transient elevation (6–12 hours)
- Best for acute intervention or periodic boosting. Not practical for daily mitochondrial maintenance
- Liposomal NR/NMN
- 200–400mg
- 40–60%
- Once daily
- Similar to sublingual but with smoother kinetics
- Emerging delivery method. Early data suggest improved steady-state levels but limited long-term trials
- Intranasal NAD+
- 50–150mg
- 20–30% (direct CNS delivery)
- CNS-specific elevation; peripheral levels less affected
- Niche application for neurological research. Bypasses blood-brain barrier but doesn't address systemic mitochondrial NAD+